ORGANIGRAM GLOBAL INC
OGINASDAQTrading Snapshot
- Day Range
- $1.21 β $1.25
- 52-Week Range
- β
- Volume
- $2.52B
- Avg Volume
- $2.58B
- Shares Outstanding
- 140.8M
- Next Earnings
- Oct 29, 2026
Fundamentals Snapshot
- Annual Revenue
- $186M
- Last Q Revenue
- $60M
- P/E Ratio
- β
- P/S Ratio
- 0.7x
- EPS (TTM)
- β
- Dividend Yield
- β
Why Investors Own OGI
- βHigh-growth profile β revenue up +57.0% YoY with expanding US Equity exposure.
- βHealthy economics β 44% gross margin and 12% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About ORGANIGRAM GLOBAL INC
Organigram Global Inc., primarily operating through its subsidiary Organigram Holdings Inc., is a Canadian enterprise specializing in the cultivation, production, and distribution of cannabis and related products. The company serves the medical cannabis market by offering products such as cannabis flowers, oils, and vaporizing devices to both civilian patients and military veterans. For adult recreational consumers, Organigram provides a diverse range of cannabis products, including edibles and concentrates, under popular brands like Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour. Additionally, the company acts as a wholesale supplier, distributing cannabis plant cuttings, dried flowers, proprietary blends, pre-rolled products, and various cannabis derivatives to retailers and other wholesalers within the adult-use recreational sector. Customers can purchase Organigram's offerings through its online platform or via telephone orders. Established in 2013, the company's corporate headquarters are located in Moncton, Canada.
Otter Score Breakdown
βAnalyst Ratings
βLatest News & Updates
Village Farms Is Undervalued As International Cannabis Revenue Hits Record Levels
Village Farms International's Q2 showed record international cannabis sales, facility expansion, cost cuts & a strong balance sheet. Read more about VFF stock.
Organigram Global Inc. (OGI:CA) Q3 2026 Earnings Call Transcript
Organigram Global Inc. (OGI:CA) Q3 2026 Earnings Call August 11, 2026 8:00 AM EDTCompany ParticipantsMax Schwartz - Director of Investor RelationsJames...
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's pre-market session. The market value of their outstanding shares is at $43.4 million. Organigram Global (NASDAQ:OGI)
OrganiGram Holdings Q3 Sales $76.413M Beat $67.660M Estimate
OrganiGram Holdings (NASDAQ:OGI) reported quarterly sales of $76.413 million which beat the analyst consensus estimate of $67.660 million by 12.94 percent. This is a 49.41 percent increase over sales of $51.142 million
Organigram Affirm Global FY2026 Revenue expected to be more than $255.197M vs $241.360M Est
Organigram Global (NASDAQ:OGI) affirm FY2026 Revenue expected to be more than $255.197M vs $241.360M Est
Sanity Group Acquisition Boosts Organigram's Quarterly Revenue
OrganigramΓ’ΒΒs acquisition by Sanity Group may boost Q3 revenue; stock trades below book amid weak cannabis sector. See more on OGI stock here.